At Paradise Genomics, we have overcome the past challenges of RNA biomarkers in the biomarker market place. Our sensitivity, precision, accuracy, and reproducibility allows us to discover actionable biomarkers for any major disease.
We have already used our process to discover biomarkers in whole BLOOD:
In addition we have a biomarker for colorectal cancer from tissue biopsies.
All of our discoveries are proprietary since they have been identified through trade secrets. We welcome new partnerships to facilitate the development of these biomarkers into new diagnostics or uncover the hidden profiles in your disease of interest.